PatentsGlobal
Aethlon Medical Advances Australian Oncology Trial and Expands Hemopurifier Patent Portfolio Through Fiscal Year 2026
Aethlon Medical, a clinical-stage company developing therapies for cancer and viral infections, announced fiscal year 2026 financial results and key corporate developments. The company progressed to the third dosing cohort in its Australian oncology trial, expanded intellectual property protections for the Hemopurifie…
Wednesday, June 10, 2026